B

BioSmart Co Ltd
KOSDAQ:038460

Watchlist Manager
BioSmart Co Ltd
KOSDAQ:038460
Watchlist
Price: 3 900 KRW 5.55% Market Closed
Market Cap: 102B KRW

Intrinsic Value

The intrinsic value of one BioSmart Co Ltd stock under the Base Case scenario is 9 068.31 KRW. Compared to the current market price of 3 900 KRW, BioSmart Co Ltd is Undervalued by 57%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
9 068.31 KRW
Undervaluation 57%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation History
BioSmart Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about BioSmart Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BioSmart Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for BioSmart Co Ltd.

Explain Valuation
Compare BioSmart Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BioSmart Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
BioSmart Co Ltd

Current Assets 158.9B
Cash & Short-Term Investments 40.9B
Receivables 47.4B
Other Current Assets 70.6B
Non-Current Assets 126.9B
Long-Term Investments 56.7B
PP&E 49.1B
Intangibles 9B
Other Non-Current Assets 12B
Current Liabilities 83.2B
Accounts Payable 22.3B
Accrued Liabilities 1.1B
Short-Term Debt 43.2B
Other Current Liabilities 16.6B
Non-Current Liabilities 66.9B
Long-Term Debt 25.6B
Other Non-Current Liabilities 41.3B
Efficiency

Free Cash Flow Analysis
BioSmart Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
BioSmart Co Ltd

Revenue
468.6B KRW
Cost of Revenue
-384.9B KRW
Gross Profit
83.7B KRW
Operating Expenses
-63B KRW
Operating Income
20.7B KRW
Other Expenses
-19B KRW
Net Income
1.7B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

BioSmart Co Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Operating Margin is Increasing
Declining Net Margin
42/100
Profitability
Score

BioSmart Co Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

BioSmart Co Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Average Altman Z-Score
56/100
Solvency
Score

BioSmart Co Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
BioSmart Co Ltd

There are no price targets for BioSmart Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BioSmart Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one BioSmart Co Ltd stock?

The intrinsic value of one BioSmart Co Ltd stock under the Base Case scenario is 9 068.31 KRW.

Is BioSmart Co Ltd stock undervalued or overvalued?

Compared to the current market price of 3 900 KRW, BioSmart Co Ltd is Undervalued by 57%.

Back to Top